HOWL
Werewolf Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Werewolf Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Werewolf Therapeutics, Inc.
0.99
−0.11 · −10.19%
post 0.99 −0.18%
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | RA Capital ManagementRA Capital Management | $859,349 | 21.80% | −64.26% | |
| 2 | Balyasny Asset ManagementBalyasny | $644,253 | 16.34% | new | |
| 3 | Vanguard Capital ManagementVanguardindex-like | $438,471 | 11.12% | 0.00% | |
| 4 | Renaissance TechnologiesRenaissance Technologies | $242,800 | 6.16% | +30.69% | |
| 5 | Lynx1 Capital ManagementLynx1 | $236,737 | 6.00% | 0.00% | |
| 6 | Sphera Funds ManagementSphera Funds | $225,589 | 5.72% | 0.00% | |
| 7 | DC FundsDC Funds | $212,018 | 5.38% | 0.00% | |
| 8 | Verdad AdvisersVerdad | $125,500 | 3.18% | +1071.74% | |
| 9 | Geode Capital ManagementGeodeindex-like | $120,895 | 3.07% | −13.78% | |
| 10 | Bank of AmericaBank of America | $111,829 | 2.84% | +17.73% | |
| 11 | XTX TopcoXTX Topco | $97,705 | 2.48% | +433.05% | |
| 12 | Jane Street GroupJane Street | $90,637 | 2.30% | +204.02% | |
| 13 | UBS GroupUBS | $77,702 | 1.97% | +222.84% | |
| 14 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $56,781 | 1.44% | 0.00% | |
| 15 | State StreetState Streetindex-like | $42,889 | 1.09% | 0.00% | |
| 16 | Squarepoint OpsSquarepoint Ops | $37,157 | 0.94% | new | |
| 17 | BlackRockBlackRockindex-like | $36,556 | 0.93% | −0.03% | |
| 18 | Rangeley CapitalRangeley Capital | $35,990 | 0.91% | new | |
| 19 | Citadel AdvisorsCitadel | $32,571 | 0.83% | +771.70% | |
| 20 | Northern TrustNorthern Trustindex-like | $31,258 | 0.79% | 0.00% | |
| 21 | Alyeska Investment GroupAlyeska Investment | $31,151 | 0.79% | 0.00% | |
| 22 | MPM Oncology Impact ManagementMPM Oncology Impact | $28,851 | 0.73% | −93.37% | |
| 23 | Millennium ManagementMillennium | $22,334 | 0.57% | −53.01% | |
| 24 | Virtu FinancialVirtu Financial | $16,000 | 0.41% | new | |
| 25 | GSA Capital PartnersGSA Capital Partners | $10,000 | 0.25% | new |
46 managers report $3.9M of Werewolf Therapeutics on form 13F for the quarter ended Jun 30 '26. 10 of them hold 80% of it; RA Capital Management is largest at 21.80%.
Expected move
Inputsspot 0.99exp Nov 20ATM strike 1ATM straddle 0.38IV 199%